High resolution magic angle spinning NMR spectroscopy for metabolic assessment of cancer presence and Gleason score in human prostate needle biopsies

[1]  H. Huisman,et al.  Standardized Threshold Approach Using Three-Dimensional Proton Magnetic Resonance Spectroscopic Imaging in Prostate Cancer Localization of the Entire Prostate , 2007, Investigative radiology.

[2]  Arend Heerschap,et al.  Proton MR spectroscopy of prostatic tissue focused on the etection of spermine, a possible biomarker of malignant behavior in prostate cancer , 2000, Magnetic Resonance Materials in Physics, Biology and Medicine.

[3]  M. Jacobs,et al.  Choline metabolism in cancer: implications for diagnosis and therapy , 2006, Expert review of molecular diagnostics.

[4]  Chi V Dang,et al.  Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.

[5]  M. Thaning,et al.  Real-time metabolic imaging. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Carroll,et al.  Quantitative analysis of prostate metabolites using 1H HR‐MAS spectroscopy , 2006, Magnetic resonance in medicine.

[7]  R. Franklin,et al.  The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots , 2006, Molecular Cancer.

[8]  Naishadh A Shah,et al.  Magnetic Resonance Spectroscopy as an Imaging Tool for Cancer: A Review of the Literature , 2006, The Journal of the American Osteopathic Association.

[9]  Leo L. Cheng,et al.  Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. , 2005, Cancer research.

[10]  M. Kattan,et al.  Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.

[11]  Metabolic profiling of normal and hypertensive rat kidney tissues by hrMAS-NMR spectroscopy , 2004, Analytical and bioanalytical chemistry.

[12]  Leo L. Cheng,et al.  Proton high‐resolution magic angle spinning NMR analysis of fresh and previously frozen tissue of human prostate , 2003, Magnetic resonance in medicine.

[13]  P. Carroll,et al.  Proton HR‐MAS spectroscopy and quantitative pathologic analysis of MRI/3D‐MRSI‐targeted postsurgical prostate tissues , 2003, Magnetic resonance in medicine.

[14]  Leo L. Cheng,et al.  High‐resolution magic angle spinning proton NMR analysis of human prostate tissue with slow spinning rates , 2003, Magnetic resonance in medicine.

[15]  J. Kurhanewicz,et al.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer , 2002, Journal of magnetic resonance imaging : JMRI.

[16]  J. Hu,et al.  High‐resolution 1H NMR spectroscopy in organs and tissues using slow magic angle spinning , 2001 .

[17]  L. True,et al.  Consensus development of a histopathological classification system for chronic prostatic inflammation , 2001, BJU international.

[18]  Leo L. Cheng,et al.  Non‐destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T , 2001, FEBS letters.

[19]  C P Langlotz,et al.  Prostate cancer: what is the future role for imaging? , 2001, AJR. American journal of roentgenology.

[20]  J Kurhanewicz,et al.  The prostate: MR imaging and spectroscopy. Present and future. , 2000 .

[21]  F. Podo.  Tumour phospholipid metabolism , 1999, NMR in biomedicine.

[22]  J. Eble.  Pathology of the Prostate , 1998 .

[23]  M. Spraul,et al.  High resolution magic angle spinning 1H nuclear magnetic resonance analysis of intact prostatic hyperplastic and tumour tissues , 1998 .

[24]  I. Smith,et al.  Diagnosis of cancer in humans by 1H NMR of tissue biopsies. , 1998, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[25]  R L Somorjai,et al.  The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. , 1997, Cancer research.

[26]  D. Grignon,et al.  Diagnostic and prognostic markers for human prostate cancer , 1997, The Prostate.

[27]  M. van der Graaf,et al.  In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue. , 1997, Anticancer research.

[28]  JeremyK. Nicholson,et al.  Proton MRS of human prostatic fluid: Correlations between citrate, spermine, and myo‐inositol levels and changes with disease , 1997, The Prostate.

[29]  J Kurhanewicz,et al.  Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. , 1995, Urology.

[30]  W. Steers,et al.  Benign prostatic hyperplasia. , 1995, Disease-a-month : DM.

[31]  Paul A. Keifer,et al.  High-Resolution 1H NMR in Solid-Phase Organic Synthesis , 1994 .

[32]  D. Bostwick.  Grading prostate cancer. , 1994, American journal of clinical pathology.

[33]  A. Heerschap,et al.  Characterization of human prostate cancer, benign prostatic hyperplasia and normal prostate by in vitro 1H and 31P magnetic resonance spectroscopy. , 1993, The Journal of urology.

[34]  J. Mohler,et al.  In vitro high resolution 1h‐spectroscopy of the human prostate: Benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma , 1993, Magnetic resonance in medicine.

[35]  J. Kurhanewicz,et al.  Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study , 1993, Magnetic resonance in medicine.

[36]  J. Bancroft,et al.  Theory and Practice of Histological Techniques , 1990 .

[37]  S. W. Nelson,et al.  Department of radiology , 1966 .

[38]  S. Meiboom,et al.  Modified Spin‐Echo Method for Measuring Nuclear Relaxation Times , 1958 .